Search Results - "Akkus, Erman"

Refine Results
  1. 1

    A SGLT2 inhibitor dapagliflozin suppresses prolonged ventricular-repolarization through augmentation of mitochondrial function in insulin-resistant metabolic syndrome rats by Durak, Aysegul, Olgar, Yusuf, Degirmenci, Sinan, Akkus, Erman, Tuncay, Erkan, Turan, Belma

    Published in Cardiovascular diabetology (17-11-2018)
    “…Metabolic syndrome (MetS) is a prevalent risk factor for cardiac dysfunction. Although SGLT2-inhibitors have important cardioprotective effects in…”
    Get full text
    Journal Article
  2. 2

    Clinical evaluation of DIAGNOVIR SARS-CoV-2 ultra-rapid antigen test performance compared to PCR-based testing by Seymen, Ali Aytac, Gulten, Ezgi, Ozgur, Erol, Ortaç, Bülend, Akdemir, Irem, Cinar, Gule, Saricaoglu, Elif Mukime, Guney-Esken, Gulen, Akkus, Erman, Can, Fusun, Karahan, Zeynep Ceren, Azap, Alpay, Tuncay, Erkan

    Published in Scientific reports (17-03-2023)
    “…Coronavirus Disease-19 (COVID-19) is a highly contagious infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Types and Rates of COVID-19 Vaccination in Patients With Newly Diagnosed Microsatellite Stable and Instable Non-Metastatic Colon Cancer by Akkus, Erman, Karaoglan, Bahar, Akyol, Cihangir, Ünal, Ali Ekrem, Kuzu, Mehmet Ayhan, Savaş, Berna, Utkan, Güngör

    Published in Curēus (Palo Alto, CA) (06-06-2024)
    “…Introduction Microsatellite instable (deficient mismatch repair, dMMR) colon cancer is associated with hypermutability and immune infiltration-activation…”
    Get full text
    Journal Article
  6. 6

    Sweet’s syndrome under ipilimumab therapy and a brief comparison of the cases in literature by Yaşar, Hatime A, Akkus, Erman, Heper, Aylin, Akay, Bengu N, Urun, Yuksel, Utkan, Gungor

    Published in Journal of oncology pharmacy practice (01-10-2020)
    “…Introduction Ipilimumab is an anti-cytotoxic T lymphocyte antigen 4 (CTLA-4) antibody. Ipilimumab has shown improvement in overall survival in patients with…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Asymptomatic pyuria and bacteriuria are not risk factors for urinary tract infection in women with type 2 diabetes mellitus initiated SGLT2 inhibitors by Akkuş, Erman, Gökçay Canpolat, Asena, Demir, Özgür, Çorapçıoğlu, Demet, Şahin, Mustafa

    Published in International urology and nephrology (01-03-2024)
    “…Purpose Asymptomatic pyuria and bacteriuria are more prevalent in diabetic patients and may be associated with urinary tract infection (UTI). The aim of this…”
    Get full text
    Journal Article
  12. 12

    Treatment approaches and survival outcomes in elderly colorectal cancer patients: a single-center comparative study by Karaoğlan, Beliz Bahar, Akkuş, Erman, Kayaalp, Mehmet, Akyol, Cihangir, Erkek, Ayhan Bülent, Akbulut, Hakan, Utkan, Güngör

    Published in Clinical & translational oncology (28-10-2024)
    “…Geriatric patients account for nearly half of new colorectal cancer (CRC) cases. This study compares clinicopathological features, treatments, outcomes, and…”
    Get full text
    Journal Article
  13. 13

    Topical aloe vera for the treatment of cetuximab-related acneiform rash in colorectal cancer: A case report by Gürbüz, Mustafa, Akkuş, Erman, Utkan, Güngör

    Published in Journal of oncology pharmacy practice (01-03-2021)
    “…Introduction Colorectal cancer is one of the most common cancers in the world. Cetuximab is an epidermal growth factor receptor (EGFR) inhibitor which provides…”
    Get full text
    Journal Article
  14. 14

    Advancements in platinum chemotherapy for metastatic castration-resistant prostate cancer: Insights and perspectives by Akkus, Erman, Arslan, Çağatay, Ürün, Yüksel

    Published in Cancer treatment reviews (01-11-2024)
    “…[Display omitted] •Platinum-based chemotherapy shows promise for mCRPC, offering a valuable option after traditional therapies fail.•Histopathological…”
    Get full text
    Journal Article
  15. 15

    Efficacy and tolerability of vismodegib treatment in locally advanced and metastatic basal cell carcinoma: Retrospective real‐life data by Gürbüz, Mustafa, Doğan, İzzet, Akkuş, Erman, Ermiş, Hande, Utkan, Güngör, Vatansever, Sezai, Taş, Faruk

    Published in Dermatologic therapy (01-11-2021)
    “…The study aims to evaluate the vismodegib treatment in local advanced (laBCC) and metastatic (mBCC) basal cell carcinoma. The data of 29 patients were…”
    Get full text
    Journal Article
  16. 16

    Thromboembolic risk in prostate cancer patients treated with PARP inhibitors: A systematic review and meta-analysis by Yazgan, Sati Coskun, Akkus, Erman, Yekeduz, Emre, Urun, Yuksel

    Published in Critical reviews in oncology/hematology (01-06-2024)
    “…Poly (ADP-ribose) polymerase inhibitors (PARPi) have been associated with thrombotic events, although the association with thrombosis risk in different cancers…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20